Shengping Li

3.3k total citations
84 papers, 1.7k citations indexed

About

Shengping Li is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Shengping Li has authored 84 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 19 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Shengping Li's work include Pancreatic and Hepatic Oncology Research (31 papers), Microbial Inactivation Methods (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Shengping Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (31 papers), Microbial Inactivation Methods (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Shengping Li collaborates with scholars based in China, United States and Czechia. Shengping Li's co-authors include Chaobin He, Xiaojun Lin, Shuxin Sun, Xin Huang, Yu Zhang, Xiang‐Ming Lao, Yize Mao, Alfred E. Chang, Hua Tang and Jun Wang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shengping Li

83 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengping Li China 24 680 467 361 315 267 84 1.7k
Shengyong Yin China 27 879 1.3× 1.3k 2.7× 547 1.5× 603 1.9× 220 0.8× 78 2.7k
Masaaki Takamura Japan 28 542 0.8× 870 1.9× 356 1.0× 332 1.1× 402 1.5× 100 2.2k
Hiroshi Tsushima Japan 19 399 0.6× 691 1.5× 167 0.5× 204 0.6× 129 0.5× 50 1.6k
Min Yu China 27 745 1.1× 950 2.0× 352 1.0× 628 2.0× 152 0.6× 119 2.2k
Amanda M. Clark United States 20 558 0.8× 468 1.0× 234 0.6× 336 1.1× 89 0.3× 38 1.3k
Mohamed H. Abdel‐Rahman United States 24 637 0.9× 943 2.0× 406 1.1× 266 0.8× 155 0.6× 81 2.4k
Ying‐Cheng Chiang Taiwan 23 552 0.8× 529 1.1× 342 0.9× 222 0.7× 166 0.6× 85 1.8k
Takafumi Sato Japan 19 1.0k 1.5× 363 0.8× 163 0.5× 323 1.0× 197 0.7× 112 1.6k
Mihai Gagea United States 27 506 0.7× 1.6k 3.4× 363 1.0× 784 2.5× 208 0.8× 62 2.4k
Jiacheng Huang China 19 409 0.6× 540 1.2× 265 0.7× 323 1.0× 245 0.9× 102 1.6k

Countries citing papers authored by Shengping Li

Since Specialization
Citations

This map shows the geographic impact of Shengping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengping Li more than expected).

Fields of papers citing papers by Shengping Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengping Li. The network helps show where Shengping Li may publish in the future.

Co-authorship network of co-authors of Shengping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shengping Li. A scholar is included among the top collaborators of Shengping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengping Li. Shengping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sun, Junbo, Yufei Wang, Xin Yang, et al.. (2025). Red mud utilization in fiber-reinforced 3D-printed concrete: Mechanical properties and environmental impact analysis. Construction and Building Materials. 462. 139830–139830. 5 indexed citations
3.
Li, Shengping, et al.. (2025). Piezoelectric spray for rapid fabrication of self-powered sensor based on sustainable textiles. Composites Part A Applied Science and Manufacturing. 195. 108979–108979. 7 indexed citations
4.
Wang, Xi, Yize Mao, Yun Yang, et al.. (2024). Multimodal single cell-resolved spatial proteomics reveal pancreatic tumor heterogeneity. Nature Communications. 15(1). 10100–10100. 14 indexed citations
5.
Li, Shengping, et al.. (2024). Unexpected piezoelectric properties of electrospun polyimide nanofibers for application in an extreme environment. Journal of Materials Chemistry C. 13(3). 1243–1253. 12 indexed citations
6.
Huang, Jinsheng, et al.. (2023). Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer. Therapeutic Advances in Medical Oncology. 15. 2630765–2630765. 3 indexed citations
7.
Zhu, Daqian, Yang Liu, Dingxin Liu, et al.. (2023). A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme‐Activatable Targeted Delivery by Sulfated Glycosaminoglycan Derivatives. Advanced Healthcare Materials. 12(17). e2203011–e2203011. 10 indexed citations
8.
Cheng, Jun, Yize Mao, Wanming Hu, et al.. (2022). Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma. Journal of Translational Medicine. 20(1). 272–272. 5 indexed citations
9.
Sun, Shuxin, Yang Liu, Chaobin He, et al.. (2021). Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer. Cancer Letters. 502. 9–24. 36 indexed citations
10.
He, Chaobin, Shuxin Sun, Yu Zhang, & Shengping Li. (2021). Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer. Journal of Inflammation Research. Volume 14. 4795–4807. 25 indexed citations
11.
Mao, Yize, Weisheng Cheng, Qiuxia Yang, et al.. (2021). The enhanced cell cycle related to the response to adjuvant therapy in pancreatic ductal adenocarcinoma. Genomics. 114(1). 95–106. 1 indexed citations
12.
He, Chaobin, Xin Huang, Yu Zhang, Xiaojun Lin, & Shengping Li. (2021). The impact of different metastatic patterns on survival in patients with pancreatic cancer. Pancreatology. 21(3). 556–563. 19 indexed citations
13.
Li, Shengping, et al.. (2020). Effect of acute normovolemic hemodilution on coronary artery bypass grafting: A systematic review and meta-analysis of 22 randomized trials. International Journal of Surgery. 83. 131–139. 10 indexed citations
14.
He, Chaobin, Shuxin Sun, Yu Zhang, Xiaojun Lin, & Shengping Li. (2020). A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection. Frontiers in Oncology. 10. 1564–1564. 4 indexed citations
15.
Li, Ye‐Xiong, Qinfu Feng, Jing Jin, et al.. (2019). Experts’ consensus on intraoperative radiotherapy for pancreatic cancer. Cancer Letters. 449. 1–7. 12 indexed citations
16.
He, Chaobin, Yu Zhang, Zhiyuan Cai, Xiaojun Lin, & Shengping Li. (2018). Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis. Journal of Cancer. 9(17). 3156–3167. 41 indexed citations
17.
Xu, Senlin, et al.. (2013). Histological response to and immunogenicity of different material patches implanted in rabbit abdominal walls. Biomedizinische Technik/Biomedical Engineering. 58(4). 323–31. 3 indexed citations
18.
19.
Lao, Xiang‐Ming, Dian Wang, Ming Shi, et al.. (2011). Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepatology Research. 41(6). 553–563. 32 indexed citations
20.
Shi, Ming, Jian Chen, Xiaojun Lin, et al.. (2009). Prospective randomized controlled study of transarterial chemoembolization with doxorubicin versus doxorubicin/lobaplatin/mitomycin combination for unresectable hepatocellular carcinoma. Clinical Oncology and Cancer Research. 36(1). 9–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengyong Yin Breakdown of academic impact, for papers by Masaaki Takamura Breakdown of academic impact, for papers by Hiroshi Tsushima Breakdown of academic impact, for papers by Min Yu Breakdown of academic impact, for papers by Amanda M. Clark Breakdown of academic impact, for papers by Mohamed H. Abdel‐Rahman Breakdown of academic impact, for papers by Ying‐Cheng Chiang Breakdown of academic impact, for papers by Takafumi Sato Breakdown of academic impact, for papers by Mihai Gagea Breakdown of academic impact, for papers by Jiacheng Huang
Rankless by CCL
2026